Releasable Conjugation of Polymers to Proteins

Bioconjugate Chemistry

Volumn 26, Issue 7, 2015, Pages 1179-1181

  Gong, Yuhui ^a   Leroux, Jean Christophe ^a   Gauthier, Marc A ^b  

^a ETH ZURICH   (Switzerland)

^b INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; COORDINATION REACTIONS; PEPTIDES; POLYETHYLENE GLYCOLS; SULFUR COMPOUNDS;

GAINING MOMENTUM; IMMUNOGENICITY; METHOXY; PEGYLATION; PEPTIDE PROTEINS; POLYMER MODIFICATIONS; PROTEIN A; SYNTHETIC STRATEGIES; THERAPEUTIC PROTEIN; TOTAL LOSS;

BIODEGRADABLE POLYMERS;

DISULFIDE; ENZYME PRECURSOR; ESTERASE; MACROGOL; MALEIC ANHYDRIDE; POLYMER; PROTEIN; THIOESTER; THIOL; AZO REDUCTASE; BENZYL DERIVATIVE; BETA ALANINE; GLYCINE; MACROGOL DERIVATIVE; N,N-BIS(2-HYDROXYETHYL)GLYCINE; OXIDOREDUCTASE; SUCCINIC ACID; THIOL DERIVATIVE;

AMINO ACID SEQUENCE; ATOM TRANSFER RADICAL POLYMERIZATION; CATALYSIS; CONJUGATION; DECARBOXYLATION; DIMERIZATION; ELIMINATION REACTION; ENZYME ACTIVITY; HALF LIFE TIME; HYDROLYSIS; IMMUNOGENICITY; MOLECULAR WEIGHT; PEPTIDE MAPPING; PH; PROTEIN DEGRADATION; PROTEIN ENGINEERING; PROTEIN INDUCTION; PROTEIN POLYMERIZATION; REVIEW; STEREOSPECIFICITY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; SYNTHESIS;

ANIMALS; BENZYL COMPOUNDS; BETA-ALANINE; GLYCINE; HUMANS; MALEIC ANHYDRIDES; MODELS, MOLECULAR; NADH, NADPH OXIDOREDUCTASES; POLYETHYLENE GLYCOLS; POLYMERS; PROTEINS; SUCCINIC ACID; SULFHYDRYL COMPOUNDS;

EID: 84937549639     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc500611k     Document Type: Review

References (77)

1. Veronese, F. M. (2001) Peptide and protein PEGylation: a review of problems and solutions Biomaterials 22, 405-417
2. Kozlowski, A. and Milton Harris, J. (2001) Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C J. Controlled Release 72, 217-224
3. Roberts, M. J., Bentley, M. D., and Harris, J. M. (2002) Chemistry for peptide and protein PEGylation Adv. Drug Delivery Rev. 54, 459-476
4. Jevševar, S., Kunstelj, M., and Porekar, V. G. (2010) PEGylation of therapeutic proteins Biotechnol. J. 5, 113-128
5. Reinders, M. K. and Jansen, T. L. T. A. (2010) New advances in the treatment of gout: review of pegloticase Journal of Therapeutics and Clinical Risk Management 6, 543-550
6. Pasut, G. and Veronese, F. M. (2007) Polymer-drug conjugation, recent achievements and general strategies Prog. Polym. Sci. 32, 933-961
7. Shannon, D. A. and Weerapana, E. (2015) Covalent protein modification: the current landscape of residue-specific electrophiles Curr. Opin. Chem. Biol. 24, 18-26
8. Gauthier, M. A. and Klok, H.-A. (2008) Peptide/protein-polymer conjugates: synthetic strategies and design concepts Chem. Commun. 2591-2611
9. Gauthier, M. A. and Klok, H.-A. (2010) Arginine-specific modification of proteins with polyethylene glycol Biomacromolecules 12, 482-493
10. Gauthier, M. A., Ayer, M., Kowal, J., Wurm, F. R., and Klok, H.-A. (2011) Arginine-specific protein modification using α-oxo-aldehyde functional polymers prepared by atom transfer radical polymerization Polym. Chem. 2, 1490-1498
11. Lee, S., Greenwald, R. B., McGuire, J., Yang, K., and Shi, C. (2001) Drug delivery systems employing 1,6-elimination: releasable poly(ethylene glycol) conjugates of proteins Bioconjugate Chem. 12, 163-169
12. Heredia, K. L., Tao, L., Grover, G. N., and Maynard, H. D. (2010) Heterotelechelic polymers for capture and release of protein-polymer conjugates Polym. Chem. 1, 168-170
13. Shaunak, S., Godwin, A., Choi, J.-W., Balan, S., Pedone, E., Vijayarangam, D., Heidelberger, S., Teo, I., Zloh, M., and Brocchini, S. (2006) Site-specific PEGylation of native disulfide bonds in therapeutic proteins Nat. Chem. Biol. 2, 312-313
14. Balan, S., Choi, J.-w., Godwin, A., Teo, I., Laborde, C. M., Heidelberger, S., Zloh, M., Shaunak, S., and Brocchini, S. (2006) Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge Bioconjugate Chem. 18, 61-76
15. Bailon, P., Palleroni, A., Schaffer, C. A., Spence, C. L., Fung, W.-J., Porter, J. E., Ehrlich, G. K., Pan, W., Xu, Z.-X., and Modi, M. W. 2001, Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C Bioconjugate Chem. 12, 195-202
16. Greenwald, R. B., Choe, Y. H., McGuire, J., and Conover, C. D. (2003) Effective drug delivery by PEGylated drug conjugates Adv. Drug Delivery Rev. 55, 217-250
17. Filpula, D. and Zhao, H. (2008) Releasable PEGylation of proteins with customized linkers Adv. Drug Delivery Rev. 60, 29-49
18. Ikeda, Y. and Nagasaki, Y. (2012) PEGylation Technology in Nanomedicine, in Polymers in Nanomedicine (Kunugi, S. and Yamaoka, T., Eds.) pp 115-140, Springer, Berlin Heidelberg.
19. Pasut, G. and Veronese, F. M. (2012) State of the art in PEGylation: The great versatility achieved after forty years of research J. Controlled Release 161, 461-472
20. Pasut, G. (2014) Polymers for Protein Conjugation Polymers 6, 160-178
21. Shechter, Y., Mironchik, M., Saul, A., Gershonov, E., Precido-Patt, L., Sasson, K., Tsubery, H., Mester, B., Kapitkovsky, A., and Rubinraut, S. 2007, New technologies to prolong life-time of peptide and protein drugs in vivo Int. J. Pept. Res. Ther. 13, 105-117
22. Shim, M. S. and Kwon, Y. J. (2012) Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications Adv. Drug Delivery Rev. 64, 1046-1059
23. Ikeda, Y. and Nagasaki, Y. (2014) Impacts of PEGylation on the gene and oligonucleotide delivery system J. Appl. Polym. Sci. 131, n/a-n/a
24. Hanai, R. and Wang, J. C. (1994) Protein footprinting by the combined use of reversible and irreversible lysine modifications Proc. Natl. Acad. Sci. U. S. A. 91, 11904-11908
25. Garman, A. J. and Barret Kalindjian, S. (1987) The preparation and properties of novel reversible polymer-protein conjugates 2-ω-Methoxypolyethylene (5000) glycoxymethylene-3-methylmaleyl conjugates of plasminogen activators FEBS Lett. 223, 361-365
26. Roberts, M. J. and Milton Harris, J. (1998) Attachment of degradable poly(ethylene glycol) to proteins has the potential to increase therapeutic efficacy J. Pharm. Sci. 87, 1440-1445
27. Butler, P. J., H, J. I., Hartley, B. S., and Lebeman, R. (1969) The use of maleic anhydride for the reversible blocking of amino groups in polypeptide chains Biochem. J. 112, 679-689
28. Woghiren, C., Sharma, B., and Stein, S. (1993) Protected thiol-polyethylene glycol: A new activated polymer for reversible protein modification Bioconjugate Chem. 4, 314-318
29. Pomroy, N. C. and Deber, C. M. (1998) Solubilization of hydrophobic peptides by reversible cysteine PEGylation Biochem. Biophys. Res. Commun. 245, 618-621
30. Azarkan, M., Maes, D., Bouckaert, J., Thi, M.-H. D., Wyns, L., and Looze, Y. (1996) Thiol pegylation facilitates purification of chymopapain leading to diffraction studies at 1.4 Å resolution J. Chromatogr., A 749, 69-72
31. Azarkan, M., Matagne, A., Wattiez, R., Bolle, L., Vandenameele, J., and Baeyens-Volant, D. (2011) Selective and reversible thiol-pegylation, an effective approach for purification and characterization of five fully active ficin (iso)forms from Ficus carica latex Phytochemistry 72, 1718-1731
32. Bontempo, D., Heredia, K. L., Fish, B. A., and Maynard, H. D. (2004) Cysteine-reactive polymers synthesized by atom transfer radical polymerization for conjugation to proteins J. Am. Chem. Soc. 126, 15372-15373
33. Wang, L., Yuan, L., Wang, H., Liu, X., Li, X., and Chen, H. (2014) New strategy for reversible modulation of protein activity through site-specific conjugation of small molecule and polymer Bioconjugate Chem. 25, 1252-1260
34. Kellogg, B. A., Garrett, L., Kovtun, Y., Lai, K. C., Leece, B., Miller, M., Payne, G., Steeves, R., Whiteman, K. R., and Widdison, W. 2011, Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage Bioconjugate Chem. 22, 717-727
35. Wu, C., Belenda, C., Leroux, J.-C., and Gauthier, M. A. (2011) Interplay of chemical microenvironment and redox environment on thiol-disulfide exchange kinetics Chem.-Eur. J. 17, 10064-10070
36. Wu, C., Wang, S., Brülisauer, L., Leroux, J.-C., and Gauthier, M. A. (2013) Broad control of disulfide stability through microenvironmental effects and analysis in complex redox environments Biomacromolecules 14, 2383-2388
37. Chen, J., Zhao, M., Feng, F., Sizovs, A., and Wang, J. (2013) Tunable thioesters as "reduction" responsive functionality for traceless reversible protein PEGylation J. Am. Chem. Soc. 135, 10938-10941
38. Greenwald, R. B., Yang, K., Zhao, H., Conover, C. D., Lee, S., and Filpula, D. (2003) Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-elimination Bioconjugate Chem. 14, 395-403
39. Xie, Y., Duan, S., and Forrest, M. L. (2010) Alkyne- and 1,6-elimination- succinimidyl carbonate-terminated heterobifunctional poly(ethylene glycol) for reversible 'Click' PEGylation Drug Discoveries Ther. 4, 240-245
40. Zalipsky, S., Mullah, N., Engbers, C., Hutchins, M. U., and Kiwan, R. (2007) Thiolytically cleavable dithiobenzyl urethane-linked polymer-protein conjugates as macromolecular prodrugs: reversible pegylation of proteins Bioconjugate Chem. 18, 1869-1878
41. Lee, S. H., Moroz, E., Castagner, B., and Leroux, J.-C. (2014) Activatable cell penetrating peptide-peptide nucleic acid conjugate via reduction of azobenzene PEG chains J. Am. Chem. Soc. 136, 12868-12871
42. Greenwald, R. B., Pendri, A., Conover, C. D., Zhao, H., Choe, Y. H., Martinez, A., Shum, K., and Guan, S. (1999) Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds J. Med. Chem. 42, 3657-3667
43. Leriche, G., Budin, G., Brino, L., and Wagner, A. (2010) Optimization of the azobenzene scaffold for reductive cleavage by dithionite; development of an azobenzene cleavable linker for proteomic applications Eur. J. Org. Chem. 2010, 4360-4364
44. Tsubery, H., Mironchik, M., Fridkin, M., and Shechter, Y. (2004) Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification J. Biol. Chem. 279, 38118-38124
45. Peleg-Shulman, T., Tsubery, H., Mironchik, M., Fridkin, M., Schreiber, G., and Shechter, Y. (2004) Reversible PEGylation: a novel technology to release native interferon α2 over a prolonged time period J. Med. Chem. 47, 4897-4904
46. Shechter, Y., Tsubery, H., Mironchik, M., Rubinstein, M., and Fridkin, M. (2005) Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice FEBS Lett. 579, 2439-2444
47. Nesher, M., Vachutinsky, Y., Fridkin, G., Schwarz, Y., Sasson, K., Fridkin, M., Shechter, Y., and Lichtstein, D. (2007) Reversible Pegylation prolongs the hypotensive effect of atrial natriuretic peptide Bioconjugate Chem. 19, 342-348
48. Shechter, Y., Mironchik, M., Rubinraut, S., Tsubery, H., Sasson, K., Marcus, Y., and Fridkin, M. (2008) Reversible pegylation of insulin facilitates its prolonged action in vivo Eur. J. Pharm. Biopharm. 70, 19-28
49. Santi, D. V., Schneider, E. L., Reid, R., Robinson, L., and Ashley, G. W. (2012) Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates Proc. Natl. Acad. Sci. U. S. A. 109, 6211-6216
50. Schneider, E. L., Robinson, L., Reid, R., Ashley, G. W., and Santi, D. V. (2013) β-Eliminative releasable linkers adapted for bioconjugation of macromolecules to phenols Bioconjugate Chem. 24, 1990-1997
51. Zhao, H., Yang, K., Martinez, A., Basu, A., Chintala, R., Liu, H.-C., Janjua, A., Wang, M., and Filpula, D. (2006) Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins Bioconjugate Chem. 17, 341-351
52. Filpula, D., Yang, K., Basu, A., Hassan, R., Xiang, L., Zhang, Z., Wang, M., Wang, Q.-c., Ho, M., and Beers, R. 2007, Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice Bioconjugate Chem. 18, 773-784
53. Pasut, G., Caboi, F., Schrepfer, R., Tonon, G., Schiavon, O., and Veronese, F. M. (2007) New active poly(ethylene glycol) derivative for amino coupling React. Funct. Polym. 67, 529-539
54. Pasut, G., Mero, A., Caboi, F., Scaramuzza, S., Sollai, L., and Veronese, F. M. (2008) A new PEG-β-alanine active derivative for releasable protein conjugation Bioconjugate Chem. 19, 2427-2431
55. Duncan, R., Gilbert, H. R. P., Carbajo, R. J., and Vicent, M. J. (2008) Polymer masked-unmasked protein therapy. 1. bioresponsive dextrin-trypsin and -melanocyte stimulating hormone conjugates designed for α-amylase activation Biomacromolecules 9, 1146-1154
56. Ferguson, E. L. and Duncan, R. (2009) Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate Biomacromolecules 10, 1358-1364
57. Ferguson, E. L., Alshame, A. M. J., and Thomas, D. W. (2010) Evaluation of hyaluronic acid-protein conjugates for polymer masked-unmasked protein therapy Int. J. Pharm. 402, 95-102
58. Reid, B., Tzeng, S., Warren, A., Kozielski, K., and Elisseeff, J. (2010) Development of a PEG derivative containing hydrolytically degradable hemiacetals Macromolecules 43, 9588-9590
59. Dingels, C., Müller, S. S., Steinbach, T., Tonhauser, C., and Frey, H. (2012) Universal concept for the implementation of a single cleavable unit at tunable position in functional poly(ethylene glycol)s Biomacromolecules 14, 448-459
60. Lundberg, P., Lee, B. F., van den Berg, S. A., Pressly, E. D., Lee, A., Hawker, C. J., and Lynd, N. A. (2012) Poly[(ethylene oxide)-co-(methylene ethylene oxide)]: A hydrolytically degradable poly(ethylene oxide) platform ACS Macro Lett. 1, 1240-1243
61. Brandl, F., Hammer, N., Blunk, T., Tessmar, J., and Goepferich, A. (2010) Biodegradable hydrogels for time-controlled release of tethered peptides or proteins Biomacromolecules 11, 496-504
62. Hammer, N., Brandl, F. P., Kirchhof, S., and Goepferich, A. M. (2014) Cleavable carbamate linkers for controlled protein delivery from hydrogels J. Controlled Release 183, 67-76
63. Georgianna, W. E., Lusic, H., McIver, A. L., and Deiters, A. (2010) Photocleavable polyethylene glycol for the light-regulation of protein function Bioconjugate Chem. 21, 1404-1407
64. Østergaard, H., Bjelke, J. R., Hansen, L., Petersen, L. C., Pedersen, A. A., Elm, T., Møller, F., Hermit, M. B., Holm, P. K., and Krogh, T. N. (2011) Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide Blood 118, 2333-41
65. Nollmann, F. I., Goldbach, T., Berthold, N., and Hoffmann, R. (2013) Controlled systemic release of therapeutic peptides from PEGylated prodrugs by serum proteases Angew. Chem., Int. Ed. 52, 7597-7599
66. Zhang, J., Yuan, Z.-F., Wang, Y., Chen, W.-H., Luo, G.-F., Cheng, S.-X., Zhuo, R.-X., and Zhang, X.-Z. (2013) Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery J. Am. Chem. Soc. 135, 5068-5073
67. Bontempo, D. and Maynard, H. D. (2005) Streptavidin as a macroinitiator for polymerization: in situ protein-polymer conjugate formation J. Am. Chem. Soc. 127, 6508-6509
68. Mueller, C., Capelle, M. A. H., Arvinte, T., Seyrek, E., and Borchard, G. (2011) Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitonin J. Pharm. Sci. 100, 1648-1662
69. 2+:nitrilotriacetic acid)n-fluorochrome conjugates J. Am. Chem. Soc. 123, 12123-12125
70. Huang, Z., Hwang, P., Watson, D. S., Cao, L., and Szoka, F. C. (2009) Tris-nitrilotriacetic acids of subnanomolar affinity toward hexahistidine tagged molecules Bioconjugate Chem. 20, 1667-1672
71. Mero, A., Ishino, T., Chaiken, I., Veronese, F., and Pasut, G. (2011) Multivalent and flexible PEG-nitrilotriacetic acid derivatives for non-covalent protein Pegylation Pharm. Res. 28, 2412-2421
72. Kim, T. H., Swierczewska, M., Oh, Y., Kim, A., Jo, D. G., Park, J. H., Byun, Y., Sadegh-Nasseri, S., Pomper, M. G., and Lee, K. C. 2013, Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo Angew. Chem. 125, 7018-7022
73. Fuhrmann, G., Grotzky, A., Lukić, R., Matoori, S., Luciani, P., Yu, H., Zhang, B., Walde, P., Schlüter, A. D., and Gauthier, M. A. 2013, Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates Nat. Chem. 5, 582-589
74. Liu, M., Tirino, P., Radivojevic, M., Phillips, D. J., Gibson, M. I., Leroux, J.-C., and Gauthier, M. A. (2013) Molecular sieving on the surface of a protein provides protection without loss of activity Adv. Funct. Mater. 23, 2007-2015
75. Liu, M., Johansen, P., Zabel, F., Leroux, J.-C., and Gauthier, M. A. (2014) Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivo. Nat. Commun. 5.
76. Nguyen, T. H., Kim, S.-H., Decker, C. G., Wong, D. Y., Loo, J. A., and Maynard, H. D. (2013) A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor Nat. Chem. 5, 221-227
77. Keefe, A. J. and Jiang, S. (2012) Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity Nat. Chem. 4, 59-63